Abstract
The aim of this multicentre prospective study was assessing the effectiveness of intravaginal treatment of vaginal candidiasis with Pimafucin 100 mg ovule. Success was obtained among 81% pregnant and 86% nonpregnant women. The negative predictive factors were intensive patients complains: pruritus or soreness.
Publication types
-
Clinical Trial
-
English Abstract
-
Multicenter Study
MeSH terms
-
Administration, Intravaginal
-
Adolescent
-
Adult
-
Antifungal Agents / therapeutic use*
-
Candidiasis, Vulvovaginal / diagnosis
-
Candidiasis, Vulvovaginal / drug therapy*
-
Female
-
Humans
-
Middle Aged
-
Natamycin / therapeutic use*
-
Predictive Value of Tests
-
Pregnancy
-
Prospective Studies
-
Treatment Outcome
Substances
-
Antifungal Agents
-
Natamycin